REQUEST A DEMO
Total
USD $0.00
Search more companies

Meribank Biotech Co., Ltd. (Taiwan, China)

Main Activities: Professional, Scientific, and Technical Services
Full name: Meribank Biotech Co., Ltd. Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Meribank Biotech Co., Ltd. is committed to promoting the concept of placenta, umbilical cord mesenchymal stem cells and umbilical cord blood storage, and providing high-quality stem cell storage services and other services. The company's main products include umbilical cord blood, stem cell storage, placental cord storage, prenatal testing, maternal and child health testing, cell viability testing, and mesenchymal stem cell storage. The company was established in 2001 and is headquartered in Taipei City, Taiwan.

Headquarters
1F., No.68, Sec. 1, Neihu Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Meribank Biotech Co., Ltd. report to view the information.

Website: http://www.meribank.com.tw

Basic Information
Total Employees:
Purchase the Meribank Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Meribank Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Meribank Biotech Co., Ltd. report to view the information.
Incorporation Date:
February 13, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.31%
Purchase this report to view the information.
0.26%
Purchase this report to view the information.
0.1%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Zhijie Biomedical Co., Ltd.
57.5%
Zimmer Smart Medical Technology Co., Ltd.
33.47%
Yuanxingju Biotechnology Co., Ltd.
4.85%
Company Performance
Financial values in the chart are available after Meribank Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
31.01%
Total operating revenue
31.01%
Operating profit (EBIT)
-12.86%
EBITDA
-25.34%
Net Profit (Loss) for the Period
-21.74%
Total assets
-13%
Total equity
-23.2%
Operating Profit Margin (ROS)
9.07%
Net Profit Margin
4.56%
Return on Equity (ROE)
-5.6%
Quick Ratio
-1.36%
Cash Ratio
-0.82%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?